Trials Starting With "P"

PACCOCATH ISR 1: Treatment of In-Stent Restenosis by Paclitaxel-Coated PTCA Balloons

      -Tiral Overview by Dr. Bruno Scheller (AHA 2006)

PACCOCATH ISR 1 and 2: Efficacy and Safety of Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis

      -2-Year Results by Dr. Bruno Scheller (TCT 2007)

 

PALLAS: Permanent Atrial FibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy

     -Trial Overview by Dr. Stuart J. Connolly (AHA 2011)

 

PAMI: The Primary Angioplasty In Myocardial Infarction Study

      -One Year Follow-Up

      -Role of Stenting in Acute MI: PAMI Stent Pilot Trial

      -6 Month Angiographic Results

 

PARIS: A Large-Scale, Prospective, Multicenter Registry Studying the Patterns of and Reasons for Non-Adherence to Antiplatelet Agents in Stented Patients

     -Study Overview by Dr. Roxana Mehran (TCT 2011)

 

PARTNER: A Prospective Randomized Trial of Transcatheter Aortic Valve Implantation Compared to Standard Therapy in Patients with Inoperable Aortic stenosis

     -A Prospective Randomized Trial of Transcatheter Aortic Valve Implantation Compared to Standard Therapy in Patients with Inoperable Aortic Stenosis by Dr. Martin Leon (TCT 2010)

     -Trial Overview by Dr. Craig Smith (ACC 2011)

 

PARTNER Cohort A: A Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement vs. Surgical Aortic Valve Replacement in High-Surgical-Risk Patients with Aortic Stenosis

     -Cost Effectiveness Trial Results by Dr. Matthew Reynolds (TCT 2011)

     -Health-Related Quality of Life Trial Results by Dr. David Cohen (TCT 2011)

 

PARTNER Cohort B: Health Related Quality of Life after Transcatheter Aortic Valve Replacement vs. Non-Surgical Therapy Among Inoperable Patients with Severe Aortic Stenosis

    -Trial Results by Dr. David A. Cohen (AHA 2010)

   -Lifetime Cost Effectiveness of Transcatheter Aortic Valve Implantation Compared with Standard Care among Inoperable Patients with Severe Aortic Stenosis by Dr. Matthew Reynolds (ACC 2011)

    -Two-Year Trial Outcomes by Dr. Raj R. Makkar (TCT 2011)

 

PASEO: Paclitaxel- or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty

      -Long-term Outcome of Drug-eluting Stents Compared with Bare Metal Stents in ST-segment Elevation Myocardial Infarction by Dr. Emilio Di Lorenzo

 

Pathways in Anticoagulation: What's Most Efficacious, Safest

      -Overview by Dr. Richard C. Becker (AHA 2010)

PCI-CURE: Effects Of Pretreatment With Clopidogrel And Aspirin Followed By Long-Term Therapy In Patients Undergoing Percutaneous Coronary Intervention:

      -Trial Overview by Dr. Maurits T. Dirksen (AHA 2006)

PCI ExTRACT-TIMI 25: PCI in Patients Receiving Enoxaparin or UFH Following Fibrinolytic Therapy for STEMI

      -Trial Overview by Dr. C. Michael Gibson (AHA 2006)

PC: Physical Counterpressure Manoeuvre Trial

      -Trial Overview by Dr. N. van Dijk (ACC 2006)

      -Trial Overview by Dr. C. Michael Gibson (AHA 2006)

PCSK9: A Randomized, Double Blind, Placebo-controlled Trial of the Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients with Primary Hypercholesterolemia

      -Trial Overview by Dr. James McKenney (ACC 2012)

PEACE: Prevention of Events with Angiotensin Converting Enzyme Inhibition

      -Trial Overview by Dr. M. Pheffer (AHA 2004)

      -Prognostic Value of B-Type Natriuretic Peptides in Patients with Stable Coronary Artery Disease by Dr. T. Omland

 

Pediatric Clinical Trials: Lessons Learned

      -Overview by Dr. Jennifer S. Li (AHA 2010)

PEECH: Prospective Evaluation of EECP in Congestive Heart Failure

      -Trial Overview by Dr. Arthur M. Feldman (ACC 2005)

 

PEPCAD-DES: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Uncoated Balloon Angioplasty in Patients with Restenosis of Drug-Eluting Stents

      -Trial Overview by Dr. Harald Rittger (TCT 2011)

 

PEPCAD II ISR: Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease

      -Paclitaxel-eluting devices: randomized comparison of the SeQuent™ please balloon catheter versus the TAXUS stent in the treatment of in-stent restenosis – 12 month follow-up of the PEPCAD II ISR study (ACC 2008)

 

PERfECT STENT: Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease

     -A Prospective, Randomized Trail Evaluating a Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease by Dr. Jochen Wohrle (TCT 2010)

 

Periprocedural MI: Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions

      -Paclitaxel-eluting devices: randomized comparison of the SeQuent™ please balloon catheter versus the TAXUS stent in the treatment of in-stent restenosis – 12 month follow-up of the PEPCAD II ISR study by Dr. Abhiram Prasad (TCT 2008)

PERISCOPE: Pioglitazone Effect On Regression Of Intravascular Sonographic Coronary Obstruction Prospective Evaluation

      -Comparison of Pioglitazone vs. Glimepiride on Progression of Coronary Atherosclerosis in Patients with Type 2 Diabetes by Dr. Steven E. Nissen

 

PERSEUS: Randomized Controlled Trial Comparison of a Novel Platinum-Chromium, Thin-Strut TAXUS Element Stent Versus the TAXUS Express Stent in de novo Coronary Stenoses

      -First Report by Dr. Dean J. Kereiakes (ACC 2010)

 

PFO Closure: PFO Closure Compared to Medical Therapy in Patients with Stroke related to PFO

    -A Prospective, Nonrandomized, Propensity-Adjusted Study of PFO Closure Compared to Medical Therapy in Patients with Stroke Presumably Related to PFO by Dr. Bernhard Meier (TCT 2010)

 

Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease:

    -Trial Overview by Dr. Dominick J. Angiolillo (CRT 2011)

 

Physicians' Health Study II: Multivitamins in the Prevention of Cardiovascular Disease in Men

    -Trial Overview by Dr. Howard D. Sesso et al. (AHA 2012)

 

Pioglitazone: Pioglitazone Reduces Neointima Formation After Coronary Stent Implantation

      -Trial Overview by Dr. Nikolaus Marx (TCT 2005)

PIOSTAT: Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein

      -Trial Overview by Dr. Markolf Hanefeld (TCT 2005)

 

Platelet Function Testing and Clinical Events: Baylor Perspective: Review of the Evidence and Are They Prime for Incorporation in Clinical Practice?

      -Overview by Dr. Mohan Sathyamoorthy (C3 Complex Intervention Meeting 2011)

 

PLATINUM: A Prospective, Randomized, Investigation of a Novel Platinum Chromium EverolimusEluting Coronary Stent

     -Trial Overview by Dr. Gregg W. Stone (ACC 2011)

PLATO: the PLATelet Inhibition and and patient Outcomes trial- Ticagrelor compared with Clopidogrel in Patients with Acute Coronary Syndromes

     -Trial Overview by Dr. Kenneth Mahaffey

      -Trial Overview by Dr. Lars Wallentin

      -Outcomes in Patients with a Planned Invasive Strategy by Dr. Christopher Cannon

 

PLATO PLATELET Substudy: Inhibitory Effects of Ticagrelor Compared to Clopidogrel on Platelet Function in Patients with Acute Coronary Syndromes

      -Study Overview by Dr. Robert F. Storey

 

PLUS: Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein

      -Ultrasound-Facilitated Thrombolysis by Dr. Douglas Weaver

 

Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction:

      -Overview by Dr. Robert W. Yeh

 

POSEIDON: A Prospective, Randomized Trial of Sliding-Scale Hydration for Prevention of Nephropathy

      -Trial Overview by Dr. Somjot S. Brar (TCT 2012)

Post-conditioning the human heart to reduce infarct size

      -Trial Overview by Dr. Douglas Weaver

PRAGUE-2: Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis

      -Long-term Outcomes of Patients with Acute Myocardial Infarction Presenting to Hospitals Without Catheterization Laboratory and Randomized to Immediate Thrombolysis or Interhospital Transport for Primary Percutaneous Coronary Intervention. Five Years’ Follow-up of the PRAGUE-2 Trial by Dr. P. Widimsky

PRAGUE-12: A Randomized, Open, Multicenter Study Comparing Cardiac Surgery with MAZE Versus Cardiac Surgery Without MAZE in Patients with Coronary and/or Valvular Heart Disease and With Atrial Fibrillation

      -Trial Overview by Dr. Petr Widimsky (ESC 2012)

PREAMI: Perindopril Remodeling In Elderly With Acute Myocardial Infarction

      -Trial Overview by Dr. Roberto Ferrari (ESC 2005)

PREDICTION: PREDICTION of Progression of Coronary Artery Disease and Clinical Outcomes Using Vascular Profiling of Shear Stress and Wall Morphology

      -Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling by Dr. Peter H. Stone

PREMIER: Effects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction

      -Protection from Distal Embolization in High-Risk Patients With Acute ST-Segment Elevation Myocardial Infarction (PREMIAR) Trial by Dr. F. Cura (ACC 2008)

PREMIAR: Protection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction

      -Trial Overview by Dr. F. Cura (ACC 2008)

PREPARE: Proximal Embolic Protection in Acute MI and Resolution of ST-Elevation

      -A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients with Acute Myocardial Infarction Undergoing Primary PCI by Dr. Karel T. Koch (TCT 2008)

      -Randomized Comparison of Primary PCI with Combined Proximal Embolic Protection and Thrombus Aspiration versus Primary PCI Alone in STEMI by Dr. Joost D.E. Haeck

 

Prevalence, Predictors, and Long-Term Prognosis of Premature Discontinuation of Oral Antiplatelet Therapy After Drug Eluting Stent Implantation:

      -Trial Overview by Dr. Dominick Angiolillo (CRT 2011)

PREVENT: Prevention of Recurrent Venous Thromboembolism

      -Trial Overview

 

PREVENT-ICARUS: Intracoronary Adenosine to Prevent Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Angioplasty

      -A Prospective, Randomized, Double-Blind Trial of Intracoronary Adenosine to Prevent Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Angioplasty by Dr. Giuseppe De Luca (TCT 2010)

 

PRIMO-CABG II: Pexelizumab for the Reduction of Infarction and Mortality in Coronary Artery Bypass Graft ll

      -Trial Overview by Dr. PA Gladding

PRINC: The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: the Plavix Response in Coronary Intervention

      -Trial Overview by Dr. Peter K. Smith (ACC 2006)

PRINCIPLE: Prasugrel In Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation

      -Trial Overview by Dr. SD Wiviott

PRISM-PLUS: Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms

      -Trial Overview

      -PRISM-PLUS: Patients with Diabetes

PROactive: Prospective Pioglitazone Clinical Trial in Macrovascular Events

      -Trial Overview by Professor Ele Ferrannini (EASD 2005)

PROBI VIRI: Prolonged Bivalirudin Infusion Versus Intraprocedural only Randomized Study

      -Trial Overview by Dr. Bernardo Cotese (TCT 2008)

 

PRODIGY: Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study

      -Study Overview by Dr. M. Valgimigli (ESC 2011)

 

PRoFESS: Prevention Regimen For Effectively avoiding Second Strokes

      -Trial Overview by Dr. Ralph Sacco, Dr. Salim Yusuf, Dr. Hans-Christof Diener (European Stroke Conference 2008)

 

PROFI: Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Distal Filter Embolic Protection in Patients Undergoing Carotid Stenting

      -Trial Overview by Dr. Klaudija Bijuklic (TCT 2011) 

 

PRO-GR: High-Dose Clopidogrel vs. Prasugrel in Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele

     - A Prospective, Randomized, Crossover Study of Maintenance High-Dose Clopidogrel vs. Prasugrel in Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele by Dr. Dimitrios Alexopoulos (TCT 2010)

 

PROGRESS-1: Clinical Performance and Angiographic Results of the Coronary Stenting with Absorbable Metal Stents

      -First-in-Man Study of an Absorbable Stent by Dr. Raimund Erbel (ACC 2006)

Progress-AMS: Clinical Performance and Angiographic Results of the Coronary Stenting with Absorbable Metal Stents

      -New Stent Technology: Magnesium-alloy by Dr. Raimund Erbel

PROMISE: Protection Devices In Pci-Treatment Of Myocardial Infarction For Salvage Of Endangered Myocardium Study

      -Trial Overview by Dr. Michael Glickl (ACC 2005)

PROSPECT: Predictors of Response to CRT

      -Trial Overview by Dr. Stefano Ghio

PROSPECT: Providing Regional Observations to Study Predictors of Events in the Coronary Tree

      -A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque by Dr. Gregg W. Stone (TCT 2009)

      -Implications from PROSPECT and Future Directions by Dr. Gregg W. Stone (CRT 2011)

 

PROSPER: Pravastatin in Elderly Individuals at Risk for Vascular Disease

      -Late Breaking Clinical Trials (AHA 2002)

 

PROTECT: Benefits of Natriuretic Peptide Guided Heart Failure Therapy for Patients With Chronic Left Ventricular Systolic Dysfunction

      -Results of the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy Study by Dr. James Januzzi (AHA 2010)

 

PROTECT II: Prospective Multicenter Randomized Trial Comparing IMPELLA to IABP in High Risk PCI

      -90-Day Results by Dr. John Lasala (C3 Complex Intervention Meeting 2011)

 

PROTECTION AMI: Selective Inhibition of Delta Protein Kinase C to Reduce Infarct Size after Primary Percutaneous Intervention for Acute Myocardial Infarction

      -Trial Overview by Dr. A Michael Lincoff  (ACC 2011)

PROTECT-TIMI 30: Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents

      -Late Breaking Clinical Trials (AHA 2005)

      -Trial Overview Part 1

      -Trial Overview Part 2

      -Trial Overview Part 3

      -Trial Overview Part 4

      -Trial results (ExTRACT TIMI-25, CLARITY TIMI-28, PROTECT TIMI-30, TIMI 31, ANTHEM TIMI-32, DISPERSE 2-TIMI 33, TITAN TIMI-34)

PROTECT AF: Percutaneous Closure of the Left Atrial Appendage versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation: A Randomized Non-Inferiority Trial

      -Trial Overview by Dr. David R. Holmes (AHA 2002)

 

PROVASA: Intra-arterial Administration of Bone-marrow Mononuclear Cells in Patients with Critical Limb Ischemia

      -Trial Overview by Dr. Dirk Walter (CRT 2011)

PROVE IT-TIMI 22: Pravastatin or Atorvastatin Evaluation and Infection Therapy

      -Late Breaking Clinical Trial by Dr. Christopher P. Cannon (ACC 2004)

PROVIDENCE: Prospective Evaluation of Rifalazil Effect On Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia Seropositive Patients

      -Trial Overview by Dr. Michael R. Jaff (AHA 2007)

 

Pulmonary Embolism Resolved with Site Specific Thrombolysis via Drug Delivery Catheter

      -Overview by Dr. Michael Nicholas (C3 Complex Intervention Meeting 2011)

 

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster